(Q39220227)

English

LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1 reference

based on heuristic

inferred from title

author name string

Tai-Kuang Chao

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Yi-Te Yo

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Yu-Ping Liao

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Yu-Chi Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Po-Hsuan Su

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Tien-Shuo Huang

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Hung-Cheng Lai

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

language of work or name

0 references

publication date

24 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

128

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

475-482

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Early events in the pathogenesis of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Focus on epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Uterine metastases in ovarian carcinoma: frequency and survival in women who underwent hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Epidemiological characteristics of ovarian cancer in Korea

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Effect of Screening on Ovarian Cancer Mortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Integrated genomic analyses of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

New insights into the pathogenesis of serous ovarian cancer and its clinical impact

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Biomarkers for epithelial-mesenchymal transitions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Ovarian cancer development and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Expression of E-cadherin transcriptional regulators in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Complex networks orchestrate epithelial-mesenchymal transitions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Ovarian surface epithelium: biology, endocrinology, and pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Epithelial-mesenchymal transition in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Identification of novel DNA methylation markers in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Characterization of LMX-1A as a metastasis suppressor in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Functions of LIM-homeobox genes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Validation of tissue microarray technology in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Tumour stem cells and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

The biology of ovarian cancer: new opportunities for translation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Hypermethylation-mediated reduction of LMX1A expression in gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Correlation of Snail expression with histological grade and lymph node status in breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Expression of CD133-1 and CD133-2 in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Cancer stem cells and EMT in carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Recurrent ovarian cancer: when and how to treat

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.12.018

7 January 2021

Identifiers

10.1016/J.YGYNO.2012.12.018

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39220227&oldid=1813627005"